Free shipping on all orders over $ 500

ARB-272572

Cat. No. M21116
ARB-272572  Structure
Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

ARB-272572 is a potent small molecule PD-L1 inhibitor that inhibits the PD-1/PD-L1 axis by inducing cell-surface PD-L1 dimerization via a cis-interacting homodimer with an IC50 value of 400 pM.

Chemical Information
Molecular Weight 568.67
Formula C32H36N6O4
CAS Number 2368182-63-0
Solubility (25°C) N/A
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Related PD-1/PD-L1 Products
Erfonrilimab

Erfonrilimab is a humanized single-domain bispecific antibody-Fc fusion protein (VH-VH-h-CH2-CH3 dimer) targeting the immune checkpoints PD-L1 and CTLA-4.

Benmelstobart

Benmelstobart is an anti-PD-L1 humanized IgG1ҡ monoclonal antibody that can be used for tumor-related studies.

Human PD-L1 inhibitor II

Human PD-L1 inhibitor II is a potent PD-L1 inhibitor with anti-cancer activity.

Human PD-L1 inhibitor I

Human PD-L1 inhibitor I is a hPD-1 peptide ligand, with a KD of 3.39 μM.

Human PD-L1 inhibitor V

Human PD-L1 inhibitor V, a human PD-1 protein binding peptide with a Kd value of 3.32 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: ARB-272572 supplier, PD-1/PD-L1, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.